'Antitumor activity' presentation slideshows

Aporphine alkaloids

Aporphine alkaloids. All the aporphine alkaloids are based on the 4H-dibenzo quinoline structure or its 3-methyl derivative commonly known as the aporphine nucleus. The numbering system is as indicated, so as to conform with the "Ring Index". Glaucine.

1.79k views • 53 slides

GDC-0449: From Corn Lilies to a Cure BCCNS Symposium September 19.2009

564 views • 38 slides

Bleomycin

Bleomycin. ???? ??????? ??? ????????? ???? 92/4/31. ??????? ?????? ????? ?????: ?.????. Taxanes. paclitaxel and docetaxel exert their cytotoxic effect by interfering with microtubule function . ( Pizzo 2011, p:325).

276 views • 26 slides

1 Vall d'Hebron University Hospital, Barcelona, Spain

A Phase 2 Multicenter Study Evaluating the Efficacy and Safety of IMC-11F8, a Recombinant Human IgG 1 Anti-Epidermal Growth Factor Receptor (EGFR) Monoclonal Antibody (MAb), Combined With 5-FU/FA and Oxaliplatin (mFOLFOX-6) as First-Line Therapy in Patients With Advanced Colorectal Cancer (CRC).

280 views • 16 slides

Synthesis, molecular docking studies and cytotoxic screening of certain novel thiazolidinone derivatives substituted wit

Substituted thiazolidinone linked to benzothiazoles and benzoxazoles 3a,b or substituted 5-benzylidene-4- thiazolidinones 4a-h were synthesized. The antitumor activity of the prepared compounds was evaluated against human breast MCF7 and liver HEPG2 cancer cell lines using Sulphorhodamine-B (SRB) assay method, doxorubicin was used as a reference standard. Most of the tested compounds showed potent antitumor activity especially the pmethoxy-5-benzylidine-4-thiazolidinone derivative of benzoxazole 4c and benzothiazole 4d, their IC50 against liver HEPG2 cancer cell line are 0.027 nM and 0.026 nM respectively. The IC50 of p-chloro-5-benzylidine-4- thiazolidinone linked to benzoxazole 4e against breast MCF7 cancer cell line, is 19 nM but, p-nitro-5-benzylidine4-thiazolidinone derivative of benzothiazole 4h showed a broad spectrum antitumor activity against MCF7 and HEPG2 cell lines, its IC50 is 36 and 48 nM respectively. The most active compounds were docked against VEGFR-2 using Moe program and 1Y6A (pdb file) to investigate if these compounds had a similar binding mode to VEGFR-2 inhibitors.

150 views • 10 slides

Center for Direct Catalytic Conversion of Biomass to Biofuels

127 views • 1 slides

Abstract (Updated)

oxaliplatin 85 mg/m 2 IV infusion. IMC-11F8 800 mg (absolute dose) IV infusion. 5-FU 400 mg/m 2 bolus infusion. 5-FU 2400 mg/m 2 continuous infusion. Rest. FA 400 mg/m 2 IV infusion. 1 hour. 2-4 minutes. 46 hours. 50 minutes. 2 hours.

262 views • 1 slides

Samir M. El-Moghazy, Nahed M. Eid, Sahar M. Abou-Seri and Shaimaa M. Abdel-Rahman *

SYNTHESIS AND IN VITRO ANTITUMOR ACTIVITY OF NEW 5-FURANOISOXAZOLINE AND 5-FURANOPYRAZOLINE DERIVATIVES. Samir M. El-Moghazy, Nahed M. Eid, Sahar M. Abou-Seri and Shaimaa M. Abdel-Rahman * Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Cairo University.

193 views • 1 slides

MAK683

tMAK683 is an inhibitor of embryonic ectoderm development protein (EED) with potential antineoplastic activity. MAK683 binds to the domain of EED that interacts with trimethylated lysine 27 on histone 3 (H3K27me3), leading to a conformational change in the EED H3K27me3-binding pocket and preventing the interaction of EED with the histone methyltransferase enhancer zeste homolog 2 (EZH2). MAK683 is undergoing phase II clinical trials for the identification of antitumor activity.

26 views • 1 slides